Close

Canada authorizes Pfizer COVID vaccine booster for adults

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Top Books Every Aspiring Pharmacist Should Read

Foundations That Shape the Profession Every pharmacist begins with a...

LOTTE BIOLOGICS Enters Contract Manufacturing Collaboration

LOTTE BIOLOGICS, on September 1, 2025, announced that it...

Cook Medical Says Extra Tariff to Be Passed to US Customers

According to medical device firm Cook Medical, the costs...

FDA Aims to Decrease Animal Testing as Tech Gathers Pace

Drug developers are raising the adoption of AI technologies...

Health Canada authorized the use of a booster dose of the Pfizer Inc (PFE.N) and BioNTech (22UAy.DE) COVID-19 vaccine for people aged 18 years and older.

The clearance of the booster shot, which can be taken at least six months after the primary regimen, would help people get additional protection against the coronavirus at a time when the Delta variant has spurred a surge in cases and hospitalizations.

The U.S. Food and Drug Administration has already authorized COVID-19 vaccine booster doses from Pfizer/BioNTech and Moderna Inc (MRNA.O) for people aged 65 and older, those at risk of severe disease and those who are exposed to the virus through their work.

Johnson & Johnson’s (JNJ.N) booster shots have also been cleared in the United States for all individuals 18 years of age and older.

Latest stories

Related stories

Top Books Every Aspiring Pharmacist Should Read

Foundations That Shape the Profession Every pharmacist begins with a...

LOTTE BIOLOGICS Enters Contract Manufacturing Collaboration

LOTTE BIOLOGICS, on September 1, 2025, announced that it...

Cook Medical Says Extra Tariff to Be Passed to US Customers

According to medical device firm Cook Medical, the costs...

FDA Aims to Decrease Animal Testing as Tech Gathers Pace

Drug developers are raising the adoption of AI technologies...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back